# PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

> **NCT07332247** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 94 (estimated)

## Conditions studied

- Nasopharangeal Cancer
- Recurrent Nasopharynx Carcinoma

## Interventions

- **RADIATION:** Selective re-irradiation
- **RADIATION:** Immediate re-irradiation

## Key facts

- **NCT ID:** NCT07332247
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-03
- **Primary completion:** 2032-02-03
- **Final completion:** 2035-02-03
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07332247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07332247, "PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07332247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*